Relapsing Multiple Sclerosis (RMS) - Market Insights, Epidemiology and Market Forecast - 2025

Publisher Name :
Date: 28-Jul-2017
No. of pages: 70
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Relapsing Multiple Sclerosis (RMS) - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Relapsing Multiple Sclerosis (RMS) for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Relapsing Multiple Sclerosis (RMS) . It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Relapsing Multiple Sclerosis (RMS) for 7 major markets.

The market outlook also provides understanding of country specific revenue and share by analyzing performance of the current therapies and thorough potential uptake of new products. Additionally, the Report highlights the frontrunners, the drivers and barriers for the Relapsing Multiple Sclerosis (RMS) market, as well as treatment algorithm, current treatments & advancements are included.The chapters including marketed products highlights the advantages and disadvantages associated with therapies associated with Relapsing Multiple Sclerosis (RMS) , providing an in-depth analysis of emerging therapies which will create an impact through their launch.

According to DelveInsight, the forecasted patient population of Relapsing Multiple Sclerosis (RMS) for the year 2025 will be XX, increasing at a CAGR of XX% from 2015 to 2025 and the Relapsing Multiple Sclerosis (RMS) 7MM market size is estimated to be USD XX by 2025.The DelveInsight Report will help in enhanced understanding of the Relapsing Multiple Sclerosis (RMS) market from inside out, with transparency into the calculated patient forecasting data and estimated market size.

Key Coverage

  • Understanding historical and forecasted epidemiological data for Relapsing Multiple Sclerosis (RMS) covering 7MM from 2015-2025.

  • Segment level epidemiology and market split for Relapsing Multiple Sclerosis (RMS) .

  • The thorough assessment of competitors, market, current trends & treatments along with upcoming treatments for Relapsing Multiple Sclerosis (RMS) .

  • The Report also covers the market size for 7MM (United States, EU 5 (Germany, Spain, Italy, France and United Kingdom) and Japan) from 2015-2025 and detailed historical and forecasted Relapsing Multiple Sclerosis (RMS) market trends.

  • Thorough market distribution based on market share for Relapsing Multiple Sclerosis (RMS) .

Reasons to buy

  • The report will help in developing business strategies by understanding trends shaping and driving the Relapsing Multiple Sclerosis (RMS) market.

  • To understand the future market competition in the Relapsing Multiple Sclerosis (RMS) market and Insightful review of the key market drivers and barriers.

  • Organize sales and marketing efforts by identifying the best opportunities for Relapsing Multiple Sclerosis (RMS) in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.

  • Identification of strong upcoming players in market will help in devising strategies that will help in getting ahead of competitors.

Relapsing Multiple Sclerosis (RMS) - Market Insights, Epidemiology and Market Forecast - 2025

Table of Contents

1. Report Introduction

2. Relapsing Multiple Sclerosis (RMS) Market Overview at a Glance
2.1. Total Market Share Distribution of Relapsing Multiple Sclerosis (RMS) for 7 MM in 2016
2.2. Total Market Share Distribution of Relapsing Multiple Sclerosis (RMS) for 7 MM in 2025

3. Relapsing Multiple Sclerosis (RMS)
3.1.1. Overview
3.1.2. Symptoms
3.1.3. Pathophysiology
3.1.4. Staging
3.1.5. Diagnosis
3.1.6. Treatment

4. Epidemiology and Patient Population
4.1.1. United States
4.1.1.1. Diagnosed Cases of Relapsing Multiple Sclerosis (RMS) in United States
4.1.2. Germany
4.1.2.1. Diagnosed Cases of Relapsing Multiple Sclerosis (RMS) in Germany
4.1.3. France
4.1.3.1. Diagnosed Cases of Relapsing Multiple Sclerosis (RMS) in France
4.1.4. Italy
4.1.4.1. Diagnosed Cases of Relapsing Multiple Sclerosis (RMS) in Italy
4.1.5. Spain
4.1.5.1. Diagnosed Cases of Relapsing Multiple Sclerosis (RMS) in Spain
4.1.6. United Kingdom
4.1.6.1. Diagnosed Cases of Relapsing Multiple Sclerosis (RMS) in United Kingdom

5. Treatment Algorithm
5.1.1. Treatment Guidelines/Practices

6. Marketed Drugs for Relapsing Multiple Sclerosis (RMS)
6.1. Drug 1: Company A
6.1.1. Drug Description
6.1.2. Mechanism of Action
6.1.3. Regulatory Milestones
6.1.4. Advantages & Disadvantages
6.1.5. Safety and Efficacy
6.1.6. Product Profile
6.1.7. Patent Status
6.2. Drug 2: Company B
6.2.1. Drug Description
6.2.2. Mechanism of Action
6.2.3. Regulatory Milestones
6.2.4. Advantages & Disadvantages
6.2.5. Safety and Efficacy
6.2.6. Product Profile
6.2.7. Patent Status

7. Emerging Therapies
7.1. Drug 3: Company C
7.1.1. Description
7.1.2. Regulatory Milestones
7.1.3. Advantages & Disadvantages
7.1.4. Product Profile
7.1.5. Launch Date
7.1.6. Clinical Development
7.1.7. Clinical Pipeline Activity
7.1.8. Ongoing Trials Information
7.1.9. Clinical Trial by Phase
7.2. Drug 4: Company B
7.2.1. Description
7.2.2. Regulatory Milestones
7.2.3. Advantages & Disadvantages
7.2.4. Product Profile
7.2.5. Launch Date
7.2.6. Clinical Development
7.2.7. Clinical Pipeline Activity
7.2.8. Ongoing Trials Information
7.2.9. Clinical Trial by Phase

8. Overview of Total Relapsing Multiple Sclerosis (RMS) Market (2016 & 2025)

9. Relapsing Multiple Sclerosis (RMS) : Country-Wise Market Analysis
9.1. United States
9.1.1. Historical Market Size (2015-2016)
9.1.2. Forecasted Market Size (2017-2025)
9.2. Germany Market Size
9.2.1. Historical Market Size (2015-2016)
9.2.2. Forecasted Market Size (2017-2025)
9.3. France Market Size
9.3.1. Historical Market Size (2015-2016)
9.3.2. Forecasted Market Size (2017-2025)
9.4. United Kingdom Market Size
9.4.1. Historical Market Size (2015-2016)
9.4.2. Forecasted Market Size (2017-2025)
9.5. Spain Market Size
9.5.1. Historical Market Size (2015-2016)
9.5.2. Forecasted Market Size (2017-2025)
9.6. Italy Market Size
9.6.1. Historical Market Size (2015-2016)
9.6.2. Forecasted Market Size (2017-2025)
9.7. Japan Market Size
9.7.1. Historical Market Size (2015-2016)
9.7.2. Forecasted Market Size (2017-2025)

10. Market Drivers

11. Market Restraints

12. Appendix

13. Report Methodology

14. Consulting Services

15. Disclaimer

16. About DelveInsight

List of Tables

Table 1: Diagnosed Cases Relapsing Multiple Sclerosis (RMS) in United States (2015-2025)
Table 2: Diagnosed Cases Relapsing Multiple Sclerosis (RMS) in Germany (2015-2025)
Table 3: Diagnosed Cases Relapsing Multiple Sclerosis (RMS) in France (2015-2025)
Table 4: Diagnosed Cases Relapsing Multiple Sclerosis (RMS) in United Kingdom (2015-2025)
Table 5: Diagnosed Cases Relapsing Multiple Sclerosis (RMS) in Spain (2015-2025)
Table 6: Diagnosed Cases Relapsing Multiple Sclerosis (RMS) in Italy (2015-2025)
Table 7: Diagnosed Cases Relapsing Multiple Sclerosis (RMS) in Japan (2015-2025)
Table 8: List of Marketed Drugs for Relapsing Multiple Sclerosis (RMS)
Table 9: List of Pipeline Phase III Drugs for Relapsing Multiple Sclerosis (RMS)
Table 10: Drug 1, Clinical Trials by Zone, 2017
Table 11: Clinical Trials by Trial status, 2017
Table 12: Drug 2, Clinical Trials by Zone, 2017
Table 13: Clinical Trials by Trial status, 2017
Table 14: Drug 3, Clinical Trials by Zone, 2017
Table 15: Clinical Trials by Trial status, 2017
Table 16: United States Market Size of Relapsing Multiple Sclerosis (RMS) in USD, Million (2015-2025)
Table 17: Germany Market Size of Relapsing Multiple Sclerosis (RMS) in USD, Million (2015-2025)
Table 18: France Market Size of Relapsing Multiple Sclerosis (RMS) in USD, Million (2015-2025)
Table 19: United Kingdom Market Size of Relapsing Multiple Sclerosis (RMS) in USD, Million (2015-2025)
Table 20: Spain Market Size of Relapsing Multiple Sclerosis (RMS) in USD, Million (2015-2025)
Table 21: Italy Market Size of Relapsing Multiple Sclerosis (RMS) in USD, Million (2015-2025)
Table 22: Japan Market Size of Relapsing Multiple Sclerosis (RMS) in USD, Million (2015-2025)

List of Figures

Figure 1: Diagnosed Cases Relapsing Multiple Sclerosis (RMS) in United States (2015-2025)
Figure 2: Diagnosed Cases Relapsing Multiple Sclerosis (RMS) in Germany (2015-2025)
Figure 3: Diagnosed Cases Relapsing Multiple Sclerosis (RMS) in France (2015-2025)
Figure 4: Diagnosed Cases Relapsing Multiple Sclerosis (RMS) in United Kingdom (2015-2025)
Figure 5: Diagnosed Cases Relapsing Multiple Sclerosis (RMS) in Spain (2015-2025)
Figure 6: Diagnosed Cases Relapsing Multiple Sclerosis (RMS) in Italy (2015-2025)
Figure 7: Diagnosed Cases Relapsing Multiple Sclerosis (RMS) in Japan (2015-2025)
Figure 8: List of Marketed Drugs for Relapsing Multiple Sclerosis (RMS)
Figure 9: List of Pipeline Phase III Drugs for Relapsing Multiple Sclerosis (RMS)
Figure 10: Drug 1, Clinical Trials by Zone (%), 2017
Figure 11: Clinical Trials by Trial status, 2017
Figure 12: Drug 2, Clinical Trials by Zone (%), 2017
Figure 13: Clinical Trials by Trial status, 2017
Figure 14: Drug 3, Clinical Trials by Zone (%), 2017
Figure 15: Clinical Trials by Trial status, 2017
Figure 16: United States Market Size of Relapsing Multiple Sclerosis (RMS) in USD, Million (2015-2025)
Figure 17: Germany Market Size of Relapsing Multiple Sclerosis (RMS) in USD, Million (2015-2025)
Figure 18: France Market Size of Relapsing Multiple Sclerosis (RMS) in USD, Million (2015-2025)
Figure 19: United Kingdom Market Size of Relapsing Multiple Sclerosis (RMS) in USD, Million (2015-2025)
Figure 20: Spain Market Size of Relapsing Multiple Sclerosis (RMS) in USD, Million (2015-2025)
Figure 21: Italy Market Size of Relapsing Multiple Sclerosis (RMS) in USD, Million (2015-2025)
Figure 22: Japan Market Size of Relapsing Multiple Sclerosis (RMS) in USD, Million (2015-2025)
  • United States Multiple Sclerosis Drugs Market Report 2017
    Published: 10-Oct-2017        Price: US 3800 Onwards        Pages: 100
    In this report, the United States Multiple Sclerosis Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth......
  • Global Fingolimod Market Professional Survey Report 2017
    Published: 09-Oct-2017        Price: US 3500 Onwards        Pages: 107
    This report studies Fingolimod in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Novartis - AstraZeneca By types, the market can be split into - O......
  • Global Multiple Sclerosis Drugs Sales Market Report 2017
    Published: 06-Oct-2017        Price: US 4000 Onwards        Pages: 105
    In this report, the global Multiple Sclerosis Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Multiple Sclerosis Drugs for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe......
  • Global Multiple Sclerosis Partnering 2010 to 2017
    Published: 01-Oct-2017        Price: US 1495 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Multiple Sclerosis Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides ......
  • Global Multiple Sclerosis Drugs Market Research Report 2017
    Published: 25-Sep-2017        Price: US 2900 Onwards        Pages: 107
    In this report, the global Multiple Sclerosis Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Multiple Sclerosis Drugs in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - ......
  • United States Fingolimod Market Report 2017
    Published: 18-Sep-2017        Price: US 3800 Onwards        Pages: 103
    In this report, the United States Fingolimod market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Fingo......
  • Global Fingolimod Sales Market Report 2017
    Published: 13-Sep-2017        Price: US 4000 Onwards        Pages: 104
    In this report, the global Fingolimod market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Fingolimod for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - Southea......
  • Multiple Sclerosis -Epidemiology Forecast to 2025
    Published: 01-Sep-2017        Price: US 2750 Onwards        Pages: 40
    DelveInsight "Multiple Sclerosis - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Multiple Sclerosis in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Multiple Sclerosis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated w......
  • Multiple Sclerosis - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Sep-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Multiple Sclerosis - Market Insights, Epidemiology and Market Forecast - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Multiple Sclerosis - Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patt......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs